Malattia linfoproliferativa post-trapianto (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malattia linfoproliferativa post-trapianto" in Italian language version.

refsWebsite

Global rank Italian rank

4^th place

9^th place

3,537^th place

1,385^th place

low place

6^th place

8^th place

alphamedpress.org

The Oncologist, su theoncologist.alphamedpress.org. URL consultato il 27 luglio 2014.

Hagenbeek A, Carde P, Meerwaldt JH, et al: European organization for research and treatment of cancer lymphoma cooperative group, Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin’s lymphoma, in J Clin Oncol, vol. 16, n. 1, 1998, pp. 41-7, PMID 9440721.

(EN) Taylor AL, Marcus R, Bradley JA, Post-transplant lymphoproliferative disorders(PTLD) after solid organ transplantation, in Crit Rev Oncol Hematol., vol. 1, n. 56, ottobre 2005, pp. 155-67, PMID 15979320.
Dotti G, Rambaldi A, Fiocchi R, et al., Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplant., in Haematologica, vol. 86, n. 6, 2001, pp. 618-23, PMID 11418370.
Shapiro RS, Chauvenet A, McGuire W, et al., Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin, in N Engl J Med, vol. 318, n. 20, 1988, p. 1334, PMID 3258958.
Hagenbeek A, Carde P, Meerwaldt JH, et al: European organization for research and treatment of cancer lymphoma cooperative group, Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin’s lymphoma, in J Clin Oncol, vol. 16, n. 1, 1998, pp. 41-7, PMID 9440721.
Smalley RV, Andersen JW, Hawkins MJ, et al., Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin’s lymphoma, in N Engl J Med, vol. 327, n. 19, 1992, pp. 1336-41, PMID 1406835.
Nepomuceno RR, Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM., Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas, in Cancer Res, vol. 63, n. 15, 2003, pp. 4472-80, PMID 12907620.